Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2021-10-16 / Eur J Cancer 2021 Oct;158:123-132Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
/in Hyperthermia, International Publications, Ovarian Cancer /von 2021-05-21 / Exp Ther Med 2021 Jul;22(1):787Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts
/in Breast Cancer, Hyperthermia, International Publications /von 2021-04-06 / Cancers (Basel) 2021 Apr;13(7)Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2021-03-17 / Mol Clin Oncol 2021 May;14(5):103Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2021-03-13 / Cancers (Basel) 2021 Mar;13(6)Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review
/in Glioblastoma, Hyperthermia, International Publications /von 2021-03-13 / J Neurooncol 2021 May;152(3):419-428Hyperthermia-Based Anti-Cancer Treatments
/in Hyperthermia, International Publications /von 2021-03-12 / Cancers (Basel) 2021 Mar;13(6)Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2021-03-01 / Gan To Kagaku Ryoho 2021 Mar;48(3):388-390Modulated Electro-Hyperthermia Facilitates NK-Cell Infiltration and Growth Arrest of Human A2058 Melanoma in a Xenograft Model
/in Hyperthermia, International Publications, Malignant Melanoma /von 2021-02-25 / Front Oncol 2021;11:590764
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de